Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLosing weight too quickly on Wegovy is a real concern, and it is one worth taking seriously. If the scale is moving faster than expected, or you have dropped below a healthy weight range, your prescriber needs to know — the right response is almost always a dose review, not a decision made on your own. Wegovy (semaglutide) is a prescription-only medicine; the trajectory of your weight loss is part of the ongoing clinical picture, not something to manage by guesswork. This page explains what rapid or unexpected loss on Wegovy typically means, when it matters clinically, and the practical steps to take.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people starting Wegovy lose weight gradually as the dose titrates upward. Rates that cause concern are generally faster than about 1 kg per week sustained over several weeks, loss that takes your BMI below the healthy range (roughly 18.5 for most adults), or loss accompanied by symptoms such as persistent fatigue, dizziness, muscle weakness, hair thinning, or difficulty concentrating. These are signals your body is not getting enough fuel or nutrients, not just fat.
It is also worth separating two different situations: losing weight faster than you expected but from a starting point where you had significant weight to lose, versus losing weight to the point where continuing on the same dose genuinely poses a health risk. The first is common and mostly reassuring with good nutrition. The second needs clinical input quickly. If you are unsure which camp you are in, that uncertainty itself is a reason to speak to your prescriber rather than waiting for the next scheduled review.
The NHS medicines page for semaglutide notes that treatment should be used alongside a reduced-calorie diet and increased activity, if your appetite suppression is so strong that you are barely eating, the balance has tipped too far and needs adjusting.
Semaglutide works by activating GLP-1 receptors in the brain and gut, dramatically reducing hunger signals and slowing gastric emptying. For most people this is the point. But GLP-1 receptor agonists do not automatically calibrate to a "safe" rate of loss, they suppress appetite consistently regardless of whether you have 30 kg left to lose or 3. If you are already seeing strong results on Wegovy and your hunger has nearly disappeared, it becomes easy to under-eat without meaning to.
The dose escalation schedule (starting at 0.25 mg and stepping up roughly every four weeks) is partly designed to prevent this kind of overshoot, but individual responses vary considerably. Some people are highly sensitive at lower doses. Others experience a step-change in effect at 1.0 mg or 1.7 mg that they did not see at earlier steps. The pace of weight loss that feels too fast can creep up over weeks, especially if you are also making dietary changes that compound the effect.
Muscle loss is the specific risk that catches people out. When weight comes off very quickly and protein intake drops, the body draws on lean mass as well as fat. That matters both for long-term metabolic health and for how you feel day to day, weakness and fatigue during a rapid loss phase are often the first signs.
First, track what you are actually eating, not to diet harder, but to check whether protein and total calorie intake have fallen below a functional level. A rough benchmark is at least 1.2 g of protein per kg of body weight per day during active weight loss; many people on semaglutide fall short of this because food feels unappealing. Getting enough feels harder when appetite is suppressed, but it protects muscle and keeps energy steady, a small high-protein snack mid-morning, for instance, is easier than a full meal for some people.
Second, contact your prescriber. If you are using Wegovy through a regulated service, this is exactly the kind of change that warrants a clinical conversation outside the routine review cycle. Your prescriber may slow down the titration, hold the current dose for longer, or in some cases suggest a temporary pause, but that call belongs to them, not to you. Taking more than prescribed is harmful; taking less without guidance can also disrupt treatment in ways that are hard to correct later.
Third, if your weight has already moved into a range you are worried about, get a GP appointment too. Wegovy requires prescriber oversight at every step; the cost and logistics of that are part of what a transparent private service covers. You can see what an end-to-end private service includes at the Wegovy cost page, where aftercare is built into the price rather than charged separately. At nume, aftercare is available seven days a week so you are not waiting until the following Monday to raise something that is bothering you on a Saturday morning.
Wegovy is licensed for long-term use as part of a managed programme, not as a short sprint to a target weight. NICE's appraisal of semaglutide (TA875) recommends it within a specialist service with multidisciplinary support, dietary guidance, activity support, and regular clinical review are part of the framework for a reason. Rapid loss that is not matched by adequate nutrition tends to rebound harder once treatment changes, because muscle loss lowers resting metabolism.
If you find yourself eating too much on some days while barely eating on others, that pattern of restriction and rebound is worth flagging too, it can sit alongside the rapid-loss problem rather than being its opposite. A consistent, moderate deficit supported by a diet that covers protein, fibre, and micronutrients is a more durable approach than riding the lowest possible intake your appetite allows.
Our prescribers review every patient's progress before each repeat, which means unexpected weight trajectories (in either direction) get caught early rather than months down the line. If you want that level of oversight built in from the start, check your eligibility for a free consultation with the nume clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.